Synthesis and computational study of 4-hydroxylbenzamide analogous as potential anti-breast cancer agent

Due to their role in cell growth and survival, HDAC (II), JAK 2 and EGFR receptors are important targets in many chemotherapies that aim to produce their biological response in malignancy solid tumors. In this work, several 4-hydroxybenzamide analogues coupled with 1,3-benzodioxole, a,ß-unsaturated...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chia Hui Low, Habsah Mohamad, Siti Fatimah Zaharah Mustafa, Khamsah Suryati Mohd, Nor Elani Mat Nafi
Formato: article
Lenguaje:EN
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://doaj.org/article/182e3f267666411a9cef620cc101cd8f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:182e3f267666411a9cef620cc101cd8f
record_format dspace
spelling oai:doaj.org-article:182e3f267666411a9cef620cc101cd8f2021-11-14T04:31:26ZSynthesis and computational study of 4-hydroxylbenzamide analogous as potential anti-breast cancer agent1878-535210.1016/j.arabjc.2021.103510https://doaj.org/article/182e3f267666411a9cef620cc101cd8f2022-01-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S1878535221005256https://doaj.org/toc/1878-5352Due to their role in cell growth and survival, HDAC (II), JAK 2 and EGFR receptors are important targets in many chemotherapies that aim to produce their biological response in malignancy solid tumors. In this work, several 4-hydroxybenzamide analogues coupled with 1,3-benzodioxole, a,ß-unsaturated carbonyl, and tert-butyl ester bases small molecules were synthesized via imidation, EDC coupling, and etherification reactions, then bio-active 4-hydroxybenzamide analogues were studied using quantum calculations and molecular docking. The Frontier molecular orbitals and energy gap values were calculated using Time-Dependent Density Functional Theory (TD-DFT). Docking results showed A and E as potent JAK2 inhibitors. B, C, and F may be good HDAC II inhibitors. D may act as a potent EGFR inhibitor. These were followed by cytotoxic evaluation of 4-hydroxybenzamide analogues on human estrogen receptor breast cancer cells (MCF-7), metastatic breast adenocarcinome cancer cells (MDA-MB-231), and fibroblast cells (NIH/3T3) respectively. Molecule E was found to have insignificant apoptosis against MCF 7 cell line and MDM-MD-231 cell lines with IC50 value 5.0 µg⁄mL and 5.0 µg⁄mL respectively.Chia Hui LowHabsah MohamadSiti Fatimah Zaharah MustafaKhamsah Suryati MohdNor Elani Mat NafiElsevierarticleBenzamide analoguesHistone deacetylase II (HDAC II) enzymesJanus kinase (JAK2) enzymesEpidermal growth factor receptor (EGFR)CytotoxicChemistryQD1-999ENArabian Journal of Chemistry, Vol 15, Iss 1, Pp 103510- (2022)
institution DOAJ
collection DOAJ
language EN
topic Benzamide analogues
Histone deacetylase II (HDAC II) enzymes
Janus kinase (JAK2) enzymes
Epidermal growth factor receptor (EGFR)
Cytotoxic
Chemistry
QD1-999
spellingShingle Benzamide analogues
Histone deacetylase II (HDAC II) enzymes
Janus kinase (JAK2) enzymes
Epidermal growth factor receptor (EGFR)
Cytotoxic
Chemistry
QD1-999
Chia Hui Low
Habsah Mohamad
Siti Fatimah Zaharah Mustafa
Khamsah Suryati Mohd
Nor Elani Mat Nafi
Synthesis and computational study of 4-hydroxylbenzamide analogous as potential anti-breast cancer agent
description Due to their role in cell growth and survival, HDAC (II), JAK 2 and EGFR receptors are important targets in many chemotherapies that aim to produce their biological response in malignancy solid tumors. In this work, several 4-hydroxybenzamide analogues coupled with 1,3-benzodioxole, a,ß-unsaturated carbonyl, and tert-butyl ester bases small molecules were synthesized via imidation, EDC coupling, and etherification reactions, then bio-active 4-hydroxybenzamide analogues were studied using quantum calculations and molecular docking. The Frontier molecular orbitals and energy gap values were calculated using Time-Dependent Density Functional Theory (TD-DFT). Docking results showed A and E as potent JAK2 inhibitors. B, C, and F may be good HDAC II inhibitors. D may act as a potent EGFR inhibitor. These were followed by cytotoxic evaluation of 4-hydroxybenzamide analogues on human estrogen receptor breast cancer cells (MCF-7), metastatic breast adenocarcinome cancer cells (MDA-MB-231), and fibroblast cells (NIH/3T3) respectively. Molecule E was found to have insignificant apoptosis against MCF 7 cell line and MDM-MD-231 cell lines with IC50 value 5.0 µg⁄mL and 5.0 µg⁄mL respectively.
format article
author Chia Hui Low
Habsah Mohamad
Siti Fatimah Zaharah Mustafa
Khamsah Suryati Mohd
Nor Elani Mat Nafi
author_facet Chia Hui Low
Habsah Mohamad
Siti Fatimah Zaharah Mustafa
Khamsah Suryati Mohd
Nor Elani Mat Nafi
author_sort Chia Hui Low
title Synthesis and computational study of 4-hydroxylbenzamide analogous as potential anti-breast cancer agent
title_short Synthesis and computational study of 4-hydroxylbenzamide analogous as potential anti-breast cancer agent
title_full Synthesis and computational study of 4-hydroxylbenzamide analogous as potential anti-breast cancer agent
title_fullStr Synthesis and computational study of 4-hydroxylbenzamide analogous as potential anti-breast cancer agent
title_full_unstemmed Synthesis and computational study of 4-hydroxylbenzamide analogous as potential anti-breast cancer agent
title_sort synthesis and computational study of 4-hydroxylbenzamide analogous as potential anti-breast cancer agent
publisher Elsevier
publishDate 2022
url https://doaj.org/article/182e3f267666411a9cef620cc101cd8f
work_keys_str_mv AT chiahuilow synthesisandcomputationalstudyof4hydroxylbenzamideanalogousaspotentialantibreastcanceragent
AT habsahmohamad synthesisandcomputationalstudyof4hydroxylbenzamideanalogousaspotentialantibreastcanceragent
AT sitifatimahzaharahmustafa synthesisandcomputationalstudyof4hydroxylbenzamideanalogousaspotentialantibreastcanceragent
AT khamsahsuryatimohd synthesisandcomputationalstudyof4hydroxylbenzamideanalogousaspotentialantibreastcanceragent
AT norelanimatnafi synthesisandcomputationalstudyof4hydroxylbenzamideanalogousaspotentialantibreastcanceragent
_version_ 1718429941767340032